ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
2.870
+0.350 (13.89%)
At close: Jun 16, 2025, 4:00 PM
2.840
-0.030 (-1.05%)
Pre-market: Jun 17, 2025, 6:35 AM EDT

ReShape Lifesciences Market Cap

ReShape Lifesciences has a market cap or net worth of $6.85 million as of June 17, 2025. Its market cap has increased by 4.26% in one year.

Market Cap
6.85M
Enterprise Value
4.46M
1-Year Change
4.26%
Ranking
Category
Stock Price
$2.87

Market Cap Chart

Since January 25, 2019, ReShape Lifesciences's market cap has increased from $2.57M to $6.85M, an increase of 166.71%. That is a compound annual growth rate of 16.60%.

History

DateMarket Cap% Change
Jun 13, 20256.01M89.16%
Dec 31, 20243.18M-31.25%
Dec 29, 20234.62M42.07%
Dec 30, 20223.25M-88.83%
Dec 31, 202129.13M46.99%
Dec 31, 202019.82M1,088.48%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 735.57B
Johnson & Johnson 377.99B
Novo Nordisk 355.28B
AbbVie 337.52B
UnitedHealth Group 284.42B
Abbott Laboratories 235.96B
Novartis AG 234.52B
AstraZeneca 231.58B
Market Cap Rankings